(Q73483312)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788181%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

The prognostic significance of Gleason Grade in patients treated with permanent prostate brachytherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788181%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788181%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Rosemary Purrazzella

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788181%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sheryl Brustein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788181%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Paul Fearn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788181%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

David Huang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788181%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Steven A Leibel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788181%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Michael W Kattan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788181%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788181%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788181%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788181%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788181%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

749-754

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788181%20AND%20SRC:MED&resulttype=core&format=json

10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900009-9

7 January 2021

American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900009-9

7 January 2021

A survey of current clinical practice of permanent prostate brachytherapy in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900009-9

7 January 2021

The impact of the biopsy Gleason score on PSA outcome for prostate cancer patients with PSA < or = 10 ng/ml and T1c,2a: implications for patient selection for prostate-only therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900009-9

7 January 2021

Isotope selection for patients undergoing prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900009-9

7 January 2021

American brachytherapy society recommendations for clinical implementation of NIST-1999 standards for (103)palladium brachytherapy. The clinical research committee of the American Brachytherapy Society

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900009-9

7 January 2021

Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900009-9

7 January 2021

The definition of biochemical failure in patients treated with definitive radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900009-9

7 January 2021

Primary Gleason pattern as a predictor of disease progression in gleason score 7 prostate cancer: a multivariate analysis of 823 men treated with radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900009-9

7 January 2021

A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900009-9

7 January 2021

A catalog of prostate cancer nomograms

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900009-9

7 January 2021

The role of external beam irradiation in patients undergoing prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900009-9

7 January 2021

The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900009-9

7 January 2021

Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900009-9

7 January 2021

External radiotherapy and permanent prostate brachytherapy in patients with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900009-9

7 January 2021

10.1016/S0360-3016(03)00009-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788181%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference